Literature DB >> 31941584

dbEMT 2.0: An updated database for epithelial-mesenchymal transition genes with experimentally verified information and precalculated regulation information for cancer metastasis.

Min Zhao1, Yining Liu2, Chong Zheng3, Hong Qu4.   

Abstract

Entities:  

Year:  2019        PMID： 31941584     DOI： 10.1016/j.jgg.2019.11.010

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN： 1673-8527            Impact factor:   4.275


× No keyword cloud information.
  16 in total

1.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

2.  Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1.

Authors:  April Lo; Kristin Holmes; Shriya Kamlapurkar; Filip Mundt; Sitapriya Moorthi; Iris Fung; Shaunt Fereshetian; Jacqueline Watson; Steven A Carr; Philipp Mertins; Alice H Berger
Journal:  Sci Signal       Date:  2021-11-30       Impact factor: 9.517

3.  Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer.

Authors:  Qiang Li; Sheng Jiang; Tienan Feng; Tengteng Zhu; Biyun Qian
Journal:  Onco Targets Ther       Date:  2021-05-12       Impact factor: 4.147

4.  NEM-Tar: A Probabilistic Graphical Model for Cancer Regulatory Network Inference and Prioritization of Potential Therapeutic Targets From Multi-Omics Data.

Authors:  Yuchen Zhang; Lina Zhu; Xin Wang
Journal:  Front Genet       Date:  2021-04-22       Impact factor: 4.599

5.  Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.

Authors:  Duangporn Saengwimol; Pamorn Chittavanich; Natanan Laosillapacharoen; Atthapol Srimongkol; Vijender Chaitankar; Duangnate Rojanaporn; Rangsima Aroonroch; Bhoom Suktitipat; Chonticha Saisawang; Saovaros Svasti; Suradej Hongeng; Rossukon Kaewkhaw
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

6.  A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma.

Authors:  Shengyu Feng; Ce Huang; Liuling Guo; Hao Wang; Hailiang Liu
Journal:  Heliyon       Date:  2022-01-05

7.  MiR-182-5p Modulates Prostate Cancer Aggressive Phenotypes by Targeting EMT Associated Pathways.

Authors:  Marilesia Ferreira Souza; Ilce Mara Syllos Cólus; Aline Simoneti Fonseca; Valquíria Casanova Antunes; Deepak Kumar; Luciane Regina Cavalli
Journal:  Biomolecules       Date:  2022-01-22

8.  Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma.

Authors:  Qi-Dong Xia; Yuan Zhang; Li-Sha Li; Jun-Lin Lu; Yang Xun; Jian-Xuan Sun; Jin-Zhou Xu; Chen-Qian Liu; Yu-Chao Lu; Deng He; Shao-Gang Wang
Journal:  Dis Markers       Date:  2022-03-23       Impact factor: 3.434

9.  Transcriptome Profiling of Embryonic Retinal Pigment Epithelium Reprogramming.

Authors:  Jared A Tangeman; Agustín Luz-Madrigal; Sutharzan Sreeskandarajan; Erika Grajales-Esquivel; Lin Liu; Chun Liang; Panagiotis A Tsonis; Katia Del Rio-Tsonis
Journal:  Genes (Basel)       Date:  2021-05-29       Impact factor: 4.141

10.  Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming.

Authors:  Kejin Hu
Journal:  Cells       Date:  2020-11-15       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.